Efficacy and safety of rituximab treatment in early primary Sjögren's syndrome: a prospective, multi-center, follow-up study
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Efficacy and safety of rituximab treatment in early primary Sjögren's syndrome: a prospective, multi-center, follow-up study
Authors
Keywords
Sicca Symptom, Minor Salivary Gland Biopsy, Extraglandular Manifestation, DMARD Group, Tertiary Lymphoid Tissue
Journal
ARTHRITIS RESEARCH & THERAPY
Volume 15, Issue 5, Pages R172
Publisher
Springer Nature
Online
2013-10-30
DOI
10.1186/ar4359
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Rituximab Therapy for Primary Sjögren's Syndrome: An Open-Label Clinical Trial and Mechanistic Analysis
- (2013) E. William St.Clair et al. ARTHRITIS AND RHEUMATISM
- Clinimetric methods in Sjögren's syndrome
- (2013) Gabriela Hernández-Molina et al. SEMINARS IN ARTHRITIS AND RHEUMATISM
- B-cell targeted therapeutics in clinical development
- (2013) Stephan Blüml et al. ARTHRITIS RESEARCH & THERAPY
- Serum levels of BAFF, but not APRIL, are increased after rituximab treatment in patients with primary Sjögren's syndrome: data from a placebo-controlled clinical trial
- (2012) Rodney P E Pollard et al. ANNALS OF THE RHEUMATIC DISEASES
- Rituximab modulates the expression of IL-22 in the salivary glands of patients with primary Sjogren's syndrome
- (2012) Francesco Ciccia et al. ANNALS OF THE RHEUMATIC DISEASES
- Efficacy of rituximab in systemic manifestations of primary Sjögren's syndrome: results in 78 patients of the AutoImmune and Rituximab registry
- (2012) Jacques-Eric Gottenberg et al. ANNALS OF THE RHEUMATIC DISEASES
- Role of lymphoid chemokines in the development of functional ectopic lymphoid structures in rheumatic autoimmune diseases
- (2012) Elisa Corsiero et al. IMMUNOLOGY LETTERS
- Sjogren’s syndrome: An update on clinical, basic and diagnostic therapeutic aspects
- (2012) A.G. Tzioufas et al. JOURNAL OF AUTOIMMUNITY
- Pathogenetic aspects of humoral autoimmunity in Sjögren's syndrome
- (2012) IP Tatouli et al. LUPUS
- B cell reconstitution and T helper cell balance after rituximab treatment of active primary Sjögren's syndrome: A double-blind, placebo-controlled study
- (2011) W. H. Abdulahad et al. ARTHRITIS AND RHEUMATISM
- Treatment of primary Sjögren's syndrome with anti-CD20 therapy (rituximab). A feasible approach or just a starting point?
- (2011) Petra M Meiners et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Treatment of Primary Sjögren Syndrome
- (2010) Manuel Ramos-Casals et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- CXCL13: a novel biomarker of B-cell return following rituximab treatment and synovitis in patients with rheumatoid arthritis
- (2010) S. Rosengren et al. RHEUMATOLOGY
- EULAR Sjogren's syndrome disease activity index: development of a consensus systemic disease activity index for primary Sjogren's syndrome
- (2009) R. Seror et al. ANNALS OF THE RHEUMATIC DISEASES
- BAFF: a local and systemic target in autoimmune diseases
- (2009) I. Moisini et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Insights into the heterogeneity of human B cells: diverse functions, roles in autoimmunity, and use as therapeutic targets
- (2009) Jennifer H. Anolik et al. IMMUNOLOGIC RESEARCH
- CD20 deficiency in humans results in impaired T cell–independent antibody responses
- (2009) Taco W. Kuijpers et al. JOURNAL OF CLINICAL INVESTIGATION
- CXCR4 Expression Functionally Discriminates Centroblasts versus Centrocytes within Human Germinal Center B Cells
- (2009) G. Caron et al. JOURNAL OF IMMUNOLOGY
- Health-related quality of life, employment and disability in patients with Sjögren's syndrome
- (2009) Jiska M. Meijer et al. RHEUMATOLOGY
- Viruses induce high expression of BAFF by salivary gland epithelial cells through TLR- and type-I IFN-dependent and -independent pathways
- (2008) Marc Ittah et al. EUROPEAN JOURNAL OF IMMUNOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search